What is the current stock price of Harrow, Inc.?

As of the latest update, Harrow, Inc.'s stock is trading at $42.93 per share.

What's happening with Harrow, Inc. stock today?

Today, Harrow, Inc. stock is up by 3.77%, possibly due to recent market activity.

What is the market sentiment around Harrow, Inc. stock?

Current sentiment around Harrow, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Harrow, Inc.'s stock price growing?

Over the past month, Harrow, Inc.'s stock price has increased by 10.27%.

How can I buy Harrow, Inc. stock?

You can buy Harrow, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol HROW.

Who are the major shareholders of Harrow, Inc. stock?

Major shareholders of Harrow, Inc. include institutions such as Opaleye Management, Inc., BlackRock, Inc., The Vanguard Group, Inc., according to the latest filings.

HROW

Harrow, Inc.

$42.93

3.77%

Trade Ideas Performance

Latest Closed Trade Idea

$42.93

3.77%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Harrow, Inc. (HROW)

In the past six months, Harrow, Inc. stock has been impacted by the report of its Fourth Quarter and Third Quarter 2025 earnings. The company announced it would report its First Quarter 2026 financial results after market close on May 11, 2026. The Centers for Medicare & Medicaid Services announced a permanent J-Code for IOPIDINE® 1%, effective July 1, 2026, which is expected to support broader adoption. The FDA cleared an Investigational New Drug (IND) application to support a planned Phase 3 clinical trial for TRIESENCE®. HROW shares increased by 64.50% over the year leading up to April 22, 2026, but decreased by 22.0% since the start of 2026 as of May 8, 2026. There were reports of major investor activity, including Opaleye Management Inc. selling shares in June 2025 and another major investor selling $7.8 million in Harrow stock in March 2026. The stock experienced a 35% pullback after conservative 2026 guidance following Q4 2025 earnings.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community